Compound Tirzepatide GIP/GLP-1
Compound Tirzepatide is the newest advancement in metabolic therapy, targeting both GIP and GLP-1 receptors for dual-action weight management. Clinical studies show patients achieving up to 20% body weight reduction. This injectable formulation ensures optimal bioavailability and consistent dosing. Administered once weekly via a simple subcutaneous injection. Compounded by licensed pharmacies to the highest quality standards.
Choose your plan:
Related Products
Oral Tirzepatide GIP/GLP-1
Oral dual GIP/GLP-1 receptor agonist for convenient, needle-free weight loss.
From $399.00/month
Compound Semaglutide GLP-1
FDA-approved GLP-1 medication for sustainable, clinically proven weight loss.
From $299.00/month
Oral Semaglutide GLP-1
Oral GLP-1 medication for needle-free weight loss with proven efficacy.
From $249.00/month
Microdose GLP-1
Low-dose GLP-1 therapy for gentle weight management and metabolic support.
From $173.00/month